5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New

Mantas Grigalavicius1, Somayeh Ezzatpanah1, Athanasios Papakyriakou2

  • 1Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.

Cancers
|August 26, 2022
PubMed

Insights

δ-aminolevulinic acid (5-ALA) effectively inhibits glioblastoma cell glycolysis and lactate dehydrogenase (LDH), leading to significant cell death. This discovery offers a promising new avenue for treating aggressive brain cancers like GBM.

Area of Science:

  • Biochemistry
  • Oncology
  • Metabolic pathways

Background:

  • Glioblastoma multiforme (GBM) exhibits high glycolytic activity, a key metabolic vulnerability.
  • δ-aminolevulinic acid (5-ALA) is known to accumulate in GBM cells.
  • Lactate dehydrogenase (LDH) plays a crucial role in glycolysis.

Purpose of the Study:

  • To investigate the effect of 5-ALA on GBM cell glycolysis and viability.
  • To determine if 5-ALA inhibits LDH.
  • To evaluate the potential of 5-ALA as a therapeutic agent for GBM.

Main Methods:

  • In silico modeling to assess 5-ALA's interaction with LDH.
  • Enzymatic and cell lysate assays to confirm LDH inhibition.
  • Cell viability assays on various GBM cell lines treated with 5-ALA.
  • Protoporphyrin IX (PpIX) production and photodynamic therapy (PDT) experiments.

Main Results:

  • 5-ALA significantly reduced glycolytic activity and ATP production in GBM cells.
  • 5-ALA was confirmed as a potent, competitive inhibitor of LDH.
  • Incubation with 5-ALA induced profound and irreversible cell death in GBM cell lines (90-98% at 10 mM within 24 h).
  • LDH inhibition by 5-ALA enhanced the efficacy of 5-ALA-based photodynamic therapy by approximately 15%.

Conclusions:

  • 5-ALA acts as a potent inhibitor of glycolysis and LDH in glioblastoma cells.
  • 5-ALA demonstrates significant anti-cancer activity against GBM, inducing substantial cell death.
  • Combining 5-ALA with PDT, particularly with prior LDH inhibition, enhances therapeutic outcomes.
  • These findings present 5-ALA as a promising therapeutic candidate for glioblastoma treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
229
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K